According to latest guidance by the State Council on reforming review system of drug and medical equipment，CFDA decided to adjust relevant regulations towards registration management of imported drug.

Drugs which are tested in China could apply for registration based on local drug registration laws and regulations. For those drugs, which already apply for registration by data from international drug testing center before this guidance was released, could still be granted with approval to import, as long as the application is up to the standard of drug registration.

Since the day when the guidance was released, Items in the new guidance, including those that conflict with the former one, will take effect immediately. (Source: CFDA)

Comments are closed.